Related Experiment Video

Updated: May 11, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

CDK4: A Key Player in the Cell Cycle, Development, and Cancer

Stacey J Baker1, E Premkumar Reddy

  • 1Mount Sinai School of Medicine, New York, NY, USA.

Genes & Cancer
|May 2, 2013
PubMed

Insights

Cyclin-dependent kinase 4 (CDK4) regulates cell cycle progression and is crucial for mammalian development and cancer. Small molecule inhibitors targeting CDK4 offer potential therapeutic strategies for various diseases.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The cell cycle is a fundamental biological process regulated by cyclins and cyclin-dependent kinases (CDKs).
  • CDK4, partnered with D-type cyclins, is essential for the G1 phase of the cell cycle, preparing cells for DNA synthesis.
  • While other CDKs can compensate for CDK4 loss in vitro, it remains vital for mammalian development and cancer progression.

Purpose of the Study:

  • To review the critical role of CDK4 in cell cycle regulation.
  • To discuss the involvement of CDK4 in normal mammalian development.
  • To explore the function of CDK4 in tumorigenesis and the therapeutic potential of CDK4 inhibitors.

Main Methods:

  • Literature review of studies on CDK4 function.
  • Analysis of data from CDK4-null mutant mice.
  • Examination of research on small molecule CDK4 inhibitors.

Main Results:

  • CDK4 plays a significant role in mammalian development despite compensatory mechanisms.
  • Dysregulation of CDK4 is implicated in various forms of cancer.
  • Small molecule inhibitors targeting CDK4 have shown promise in preclinical studies.

Conclusions:

  • CDK4 is a key regulator of the cell cycle and a critical factor in development and cancer.
  • Targeting CDK4 with small molecule inhibitors represents a viable therapeutic approach for treating CDK4-driven diseases.
Keywords:
CDK4cancercell cycleknockouttargeted therapy

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.